# Evaluation of Novel Dually Targeted Kinase Inhibitors for Therapy of Adult and Pediatric High-Grade Glioma

> **NIH NIH R33** · UNIVERSITY OF TX MD ANDERSON CAN CTR · 2021 · $365,801


## Key facts

- **NIH application ID:** 10173926
- **Project number:** 5R33NS111058-03
- **Recipient organization:** UNIVERSITY OF TX MD ANDERSON CAN CTR
- **Principal Investigator:** Joya Chandra
- **Activity code:** R33 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $365,801
- **Award type:** 5
- **Project period:** 2019-05-01 → 2024-05-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10173926

## Citation

> US National Institutes of Health, RePORTER application 10173926, Evaluation of Novel Dually Targeted Kinase Inhibitors for Therapy of Adult and Pediatric High-Grade Glioma (5R33NS111058-03). Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/grant/nih/10173926. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*